Fuan Pharmaceutical (Group) Co Ltd Class A 300194
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.29
- Day Range
- CNY 4.26–4.40
- 52-Week Range
- CNY 2.92–5.15
- Bid/Ask
- CNY 4.37 / CNY 4.38
- Market Cap
- CNY 5.21 Bil
- Volume/Avg
- 22.9 Mil / 32.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 17.38
- Price/Sales
- 1.89
- Dividend Yield (Trailing)
- 1.17%
- Dividend Yield (Forward)
- 1.17%
- Total Yield
- 1.17%
Company Profile
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,292
- Website
- http://www.fapharm.com
Comparables
Valuation
Metric
|
300194
|
603367
|
002898
|
---|---|---|---|
Price/Earnings (Normalized) | 17.38 | 16.02 | — |
Price/Book Value | 1.19 | 1.27 | 3.52 |
Price/Sales | 1.89 | 1.68 | 6.29 |
Price/Cash Flow | 9.49 | 12.58 | 79.40 |
Price/Earnings
300194
603367
002898
Financial Strength
Metric
|
300194
|
603367
|
002898
|
---|---|---|---|
Quick Ratio | 1.18 | 2.84 | 0.58 |
Current Ratio | 1.77 | 3.62 | 1.04 |
Interest Coverage | 10.96 | 84.52 | −1.91 |
Quick Ratio
300194
603367
002898
Profitability
Metric
|
300194
|
603367
|
002898
|
---|---|---|---|
Return on Assets (Normalized) | 0.94% | 6.25% | −0.31% |
Return on Equity (Normalized) | 1.40% | 7.93% | −0.47% |
Return on Invested Capital (Normalized) | 1.12% | 7.24% | 0.41% |
Return on Assets
300194
603367
002898
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zmlxnqgg | Srzs | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Ymyyfjzy | Vfkjmcf | $72.9 Bil | |
HLN
| Haleon PLC ADR | Wdzjbml | Tmt | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xcrybdw | Slgt | $18.3 Bil | |
VTRS
| Viatris Inc | Dkndrvyl | Xmmv | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kktbqvv | Gjrxj | $11.7 Bil | |
CTLT
| Catalent Inc | Dsmkjvkph | Ndspyh | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bckyldndt | Kyxmc | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Nwqpphmr | Tfkjq | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fvzlnbshp | Gvlhf | $3.5 Bil |